Product Highlight - GALVUS MET
As demonstrated by VERIFY study:
- Early combination treatment strategy of Galvus Met was superior to standard of care metformin monotherapy: Offers 2 extra years of glycemic control1
- Hypoglycemia and adverse event were not significantly increased with early initiation of Galvus Met vs metformin monotherapy1
- Endorsed by ADA 2020 Guideline: Early treatment combination therapy can be considered at treatment initiation to extend the time to treatment failure in some patients2
1) Matthews DR et al. Lancet. 2019;394:1519-1529;
2) American Diabetes Association. (2020). 7. Diabetes Technology: Standards of Medical Care in Diabetes-2020.Diabetes Care,43(Supplement 1), S77-S88.
3) Prescribing information available at https://www.novartis.com.my/product-list-v2/products?sort_bef_combine=title+ASC&sort_bef_combine=title+ASC&combine=galvus+met